Skin Cell Renewal Treaments

Aramore's NAD+ Cell Energizing Treatment Enhances Firmness & Tone

Every day skin cell renewal is supported with Aramore's hero product, the NAD+ Cell Energizing Treatment, and the transformative results it provides speaks for itself. Using the hydrating, clinically proven treatment, the company ran an eight-week independent clinical human trial on 29 women ages 44 to 61, and findings showed that 100% of participants saw significant improvement across metrics of skin aging, including skin hydration; radiance and brightness; skin texture and smoothness; skin tone; overall healthy appearance of skin; skin homogeneity; dark spot intensity reduction; and hyperpigmentation reduction.

The NAD+ Cell Energizing Treatment is one key piece of The NAD+ Trio, alongside the deeply moisturizing NAD+ Cell Restoration Cream and the NAD+ Renewing Eye Cream.

Nad+ Topicalization
The translation of NAD+ molecules into stable, skin-penetrating topical formats creates potential for clinically measurable anti-aging products that converge cosmeceuticals with cellular bioenergetics.
Evidence-based Cosmetic Claims
Independent, human clinical trials producing quantifiable multi-metric improvements enable a new class of trust-driven brands that differentiate through verified efficacy rather than marketing alone.
Multi-product Treatment Systems
Bundled regimens like targeted trios that combine energizing serums with restoration creams open avenues for platform-based subscription models centered on staged cellular repair and maintenance.

Industries Being Reshaped

Skincare and Cosmetics
Formulation houses and brands stand to be reshaped by demand for bioactive ingredient stabilization and delivery systems that produce lab-validated skin rejuvenation outcomes.
Clinical Dermatology
Specialist clinics could pivot toward offering protocolized NAD+-based therapies that blur lines between medical treatments and high-efficacy aesthetic services.
Longevity Biotech
Companies working on cellular metabolism and NAD+ biology may expand into consumer-facing topical therapeutics that translate systemic longevity science into localized skin interventions.
SCORE
8.1 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Gen X
  • Millennial (primary audience)
POPULARITY
Popularity 80%
Activity 86%
Freshness 77%